SPG3A

Spastic paraplegia 3A (autosomal dominant)
Identifiers
Symbols	SPG3A ; GBP3; AD-FSP; ATL1; FSP1; SPG3; atlastin1
External IDs	Template:OMIM5 Template:MGI HomoloGene: 9302
Gene ontology Molecular function Template:GNF GO Template:GNF GO Template:GNF GO Biological process Template:GNF GO
Orthologs
Template:GNF Ortholog box
Species	Human	Mouse
Entrez	n/a	n/a
Ensembl	n/a	n/a
UniProt	n/a	n/a
RefSeq (mRNA)	n/a	n/a
RefSeq (protein)	n/a	n/a
Location (UCSC)	n/a	n/a
PubMed search	n/a	n/a

Spastic paraplegia 3A (autosomal dominant), also known as SPG3A, is a human gene.

Further reading

• Gispert S, Santos N, Damen R; et al. (1995). "Autosomal dominant familial spastic paraplegia: reduction of the FSP1 candidate region on chromosome 14q to 7 cM and locus heterogeneity". Am. J. Hum. Genet. 56 (1): 183–7. PMID 7825576.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Maruyama K, Sugano S (1994). "Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides". Gene. 138 (1–2): 171–4. PMID 8125298.
• Hazan J, Lamy C, Melki J; et al. (1994). "Autosomal dominant familial spastic paraplegia is genetically heterogeneous and one locus maps to chromosome 14q". Nat. Genet. 5 (2): 163–7. doi:10.1038/ng1093-163. PMID 8252041.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Andersson B, Wentland MA, Ricafrente JY; et al. (1996). "A "double adaptor" method for improved shotgun library construction". Anal. Biochem. 236 (1): 107–13. doi:10.1006/abio.1996.0138. PMID 8619474.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Yu W, Andersson B, Worley KC; et al. (1997). "Large-scale concatenation cDNA sequencing". Genome Res. 7 (4): 353–8. PMID 9110174.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K; et al. (1997). "Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library". Gene. 200 (1–2): 149–56. PMID 9373149.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Zhao X, Alvarado D, Rainier S; et al. (2001). "Mutations in a newly identified GTPase gene cause autosomal dominant hereditary spastic paraplegia". Nat. Genet. 29 (3): 326–31. doi:10.1038/ng758. PMID 11685207.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Muglia M, Magariello A, Nicoletti G; et al. (2002). "Further evidence that SPG3A gene mutations cause autosomal dominant hereditary spastic paraplegia". Ann. Neurol. 51 (6): 794–5. doi:10.1002/ana.10185. PMID 12112092.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Luan Z, Zhang Y, Liu A; et al. (2002). "A novel GTP-binding protein hGBP3 interacts with NIK/HGK". FEBS Lett. 530 (1–3): 233–8. PMID 12387898.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Strausberg RL, Feingold EA, Grouse LH; et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMID 12477932.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Tessa A, Casali C, Damiano M; et al. (2003). "SPG3A: An additional family carrying a new atlastin mutation". Neurology. 59 (12): 2002–5. PMID 12499504.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Heilig R, Eckenberg R, Petit JL; et al. (2003). "The DNA sequence and analysis of human chromosome 14". Nature. 421 (6923): 601–7. doi:10.1038/nature01348. PMID 12508121.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Dalpozzo F, Rossetto MG, Boaretto F; et al. (2004). "Infancy onset hereditary spastic paraplegia associated with a novel atlastin mutation". Neurology. 61 (4): 580–1. PMID 12939451.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Zhu PP, Patterson A, Lavoie B; et al. (2004). "Cellular localization, oligomerization, and membrane association of the hereditary spastic paraplegia 3A (SPG3A) protein atlastin". J. Biol. Chem. 278 (49): 49063–71. doi:10.1074/jbc.M306702200. PMID 14506257.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Wilkinson PA, Hart PE, Patel H; et al. (2004). "SPG3A mutation screening in English families with early onset autosomal dominant hereditary spastic paraplegia". J. Neurol. Sci. 216 (1): 43–5. PMID 14607301.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Sauter SM, Engel W, Neumann LM; et al. (2004). "Novel mutations in the Atlastin gene (SPG3A) in families with autosomal dominant hereditary spastic paraplegia and evidence for late onset forms of HSP linked to the SPG3A locus". Hum. Mutat. 23 (1): 98. doi:10.1002/humu.9205. PMID 14695538.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• D'Amico A, Tessa A, Sabino A; et al. (2004). "Incomplete penetrance in an SPG3A-linked family with a new mutation in the atlastin gene". Neurology. 62 (11): 2138–9. PMID 15184642.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Hedera P, Fenichel GM, Blair M, Haines JL (2004). "Novel mutation in the SPG3A gene in an African American family with an early onset of hereditary spastic paraplegia". Arch. Neurol. 61 (10): 1600–3. doi:10.1001/archneur.61.10.1600. PMID 15477516.CS1 maint: Multiple names: authors list (link)
• Gerhard DS, Wagner L, Feingold EA; et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)". Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMID 15489334.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Abel A, Fonknechten N, Hofer A; et al. (2005). "Early onset autosomal dominant spastic paraplegia caused by novel mutations in SPG3A". Neurogenetics. 5 (4): 239–43. doi:10.1007/s10048-004-0191-2. PMID 15517445.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)